首页 正文

Leveraging circulating microRNAs for personalized disease-modifying therapies in type 1 diabetes

{{output}}
Type 1 Diabetes (T1D) is a chronic autoimmune disease marked by the progressive immune-mediated destruction of insulin-producing pancreatic beta-cells. The clinical management of T1D is complicated by its heterogeneity and the variability in individual respons... ...